BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 21771749)

  • 1. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
    Mitwalli AH; Hayat A; Alwakeel J; Hammad D
    Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.
    Mitwalli AH; Alam A; Al-Wakeel J; Al Suwaida K; Tarif N; Schaar TA; Al Adbha B; Hammad D
    Nephron Clin Pract; 2006; 102(2):c72-80. PubMed ID: 16244496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis.
    Ayodele OE; Okpechi IG; Swanepoel CR
    Nephrology (Carlton); 2010 Jun; 15(4):482-90. PubMed ID: 20609103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
    Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
    Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal transplantation in lupus nephritis: a Brazilian cohort.
    Oliveira CS; d Oliveira I; Bacchiega AB; Klumb EM; Albuquerque EM; Souza E; Suassuna JH; Ribeiro FM
    Lupus; 2012 Apr; 21(5):570-4. PubMed ID: 22129601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.
    Chrysochou C; Randhawa H; Reeve R; Waldek S; Wood GN; O'Donoghue DJ; Kalra PA
    QJM; 2008 Apr; 101(4):313-6. PubMed ID: 18270227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class V lupus nephritis: a clinicopathologic study in 152 patients.
    Chen Q; Liu Z; Hu W; Chen H; Zeng C; Li L
    J Nephrol; 2003; 16(1):126-32. PubMed ID: 12653107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.
    Heras M; Fernández-Reyes MJ; Sánchez R; Guerrero MT; Molina A; Rodríguez MA; Alvarez-Ude F
    Nefrologia; 2012 May; 32(3):300-5. PubMed ID: 22508140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.
    Huo TI; Yang WC; Wu JC; King KL; Lin CY; Loong CC; Lui WY; Chang FY; Lee SD
    Hepatogastroenterology; 2001; 48(37):169-73. PubMed ID: 11268958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.
    Al Arfaj AS; Khalil N; Al Saleh S
    Rheumatol Int; 2009 Jul; 29(9):1057-67. PubMed ID: 19381639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
    Lemos LB; Perez RM; Lemos MM; Draibe SA; Silva IS; Silva AE; Ferraz ML
    Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
    J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis.
    Faurschou M; Dreyer L; Kamper AL; Starklint H; Jacobsen S
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):873-80. PubMed ID: 20191478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
    Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.